This topic contains a solution. Click here to go to the answer

Author Question: What is one of the main intended responses of fibrates? a. Increased triglycerides b. Increased ... (Read 43 times)

leo leo

  • Hero Member
  • *****
  • Posts: 566
What is one of the main intended responses of fibrates?
 
  a. Increased triglycerides
  b. Increased blood clotting
  c. Increased LDL cholesterol
  d. Increased HDL cholesterol

Question 2

A pediatric patient is prescribed 0.008 mg of digoxin (Lanoxin). The drug on hand is digoxin 0.05 mg/mL. One milliliter equals 15 gtt. How many drops (gtt) will you give?
 
  What is the answer?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jamesnevil303

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

ANS: D

Answer to Question 2

2



leo leo

  • Hero Member
  • *****
  • Posts: 566
Both answers were spot on, thank you once again




 

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library